( Bloomberg:NANO@NO, ISIN:NO0010597883, Oslo:NANO, RICS:NANO.OL )

News from Nordic Nanovector A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 23, 2018, 13:04 ET Nordic Nanovector ASA - Issuance of PSUs

The Board of Directors of Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") has on 23 April 2018 resolved to grant 15 000 Performance...


Apr 20, 2018, 08:57 ET Nordic Nanovector Appoints Tone Kvåle as Interim Chief Executive Officer

Nordic Nanovector ASA (OSE: NANO) announces that it has appointed Tone Kvåle to the position of Interim Chief Executive Officer (CEO) in addition...


Apr 16, 2018, 01:15 ET Nordic Nanovector Presents Preclinical Data at AACR 2018

Nordic Nanovector ASA (OSE: NANO) announces that a poster reporting the anti-tumour effect of Humalutin® (177Lu-conjugated humanized anti-CD37...


Apr 05, 2018, 11:07 ET Nordic Nanovector ASA: Mandatory Notification of Trade - Primary Insider

Luigi Costa has today, 5 April 2018, purchased 10,000 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 43.56 per...


Apr 04, 2018, 16:32 ET Nordic Nanovector Provides Update on the PARADIGME Clinical Trial

Nordic Nanovector ASA (OSE: NANO) today provides an update on its clinical development programme, including updated guidance on expected milestones...


Apr 04, 2018, 15:54 ET Nordic Nanovector Announces that Luigi Costa Will Step Down as Chief Executive Officer

Nordic Nanovector ASA (OSE: NANO) announces that Luigi Costa, will step down as Chief Executive Officer by mutual agreement with the Board of...


Mar 15, 2018, 02:27 ET Nordic Nanovector to Present Preclinical Data Highlighting the Anti-tumor Effect of Humalutin® in Three Lymphoma Models at AACR 2018

Nordic Nanovector ASA (OSE: NANO) announces that it will present a poster reporting the anti-tumour effect of Humalutin® (177Lu-conjugated humanized...


Mar 12, 2018, 02:17 ET Nordic Nanovector to Present at the China Healthcare Investing and Partnering Symposium in China and Stifel Nordic Healthcare Seminar in London

Nordic Nanovector ASA (OSE: NANO) announces that the company will be presenting at the following upcoming investor conferences: - The...


Feb 27, 2018, 01:16 ET Nordic Nanovector ASA - Results for the Fourth Quarter and Full Year 2017: Solid Performance Through 2017, Moving Forward With Pivotal Trial

Nordic Nanovector ASA (OSE: NANO) announces results for the fourth quarter and full year 2017. A presentation by the company's team will take...


Feb 20, 2018, 01:12 ET Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2017 Results Presentation and Webcast

Nordic Nanovector ASA (OSE: NANO) announces its fourth quarter and full year 2017 results on Tuesday, 27th of February 2018. A presentation by...


Feb 05, 2018, 03:04 ET Nordic Nanovector ASA - Allocation of PSUs

Malene Brondberg, VP IR & CC has been granted 20,000 performance share units ("PSUs") in connection with her appointment. For further...


Feb 01, 2018, 01:55 ET Nordic Nanovector Appoints Malene Brondberg as Vice President, Investor Relations and Corporate Communications

Nordic Nanovector ASA (OSE: NANO) announces that Ms. Malene Brondberg has been appointed as Vice President, Investor Relations and Corporate...


Jan 29, 2018, 04:02 ET Nordic Nanovector ASA - Allocation of PSUs

The Board of Directors of Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") has on 29th of January 2018 decided to grant 216 550...


Dec 20, 2017, 07:12 ET Nordic Nanovector ASA - Extraordinary General Meeting Held

An Extraordinary General Meeting of Nordic Nanovector ASA (the "Company") (OSE: NANO) was held today on 20 December 2017 in Oslo, Norway (the...


Dec 12, 2017, 08:40 ET Nordic Nanovector to Present at DNB Nordic Healthcare Conference

Nordic Nanovector ASA (OSE: NANO) announces that the company will be presenting at the DNB Nordic Healthcare Conference on 14th of December 2017...


Dec 11, 2017, 01:23 ET Betalutin® Shows Strong Clinical Profile in Relapsed/refractory Indolent NHL and Follicular Lymphoma

Nordic Nanovector ASA (OSE: NANO) has presented updated results from its LYMRIT 37-01 Phase 1/2 clinical study of Betalutin®...


Dec 08, 2017, 02:05 ET Nordic Nanovector: Invitation to Conference Call for Updated Results From the LYMRIT 37-01 Phase 1/2 Trial, to be Presented at ASH

Nordic Nanovector ASA (OSE: NANO) will host a conference call and audio cast on Monday 11 December at 08:00 CET to present the updated results from...


Dec 04, 2017, 04:50 ET Nordic Nanovector to Present at Carnegie Nordic Healthcare Day

Nordic Nanovector ASA (OSE: NANO) announces that the company will be presenting at the Carnegie Nordic Healthcare day on 5th of December 2017 in...


Nov 29, 2017, 12:44 ET Nordic Nanovector: Notice of Extraordinary General Meeting

The Board of Directors of Nordic Nanovector ASA call for an Extraordinary General Meeting to be held at Thon Hotel Vika Atrium, Munkedamsveien...


Nov 22, 2017, 02:35 ET Nordic Nanovector Capital Markets Day 2017

The presentations will be held by members of the executive management team as well as selected external expert speakers, including Prof. Pier Luigi...


Nov 22, 2017, 01:52 ET Nordic Nanovector ASA - Results for the Third Quarter 2017

Nordic Nanovector ASA (OSE: NANO) announces results for the third quarter 2017. A presentation by the company's senior management team will take...


Nov 15, 2017, 08:05 ET Nordic Nanovector ASA - Financial Calendar

FINANCIAL YEAR 2017 Quarterly Report - Q3 22.11.2017 Quarterly Report - Q4 27.02.2018 Capital Markets Day 22.11.2017 FINANCIAL YEAR 2018...


Nov 13, 2017, 05:26 ET Nordic Nanovector to Present at Jefferies Global Healthcare Conference

Nordic Nanovector ASA (OSE: NANO) announces that the company will be presenting at the Jefferies Global Healthcare Conference on 15th of November...


Nov 08, 2017, 03:03 ET Nordic Nanovector: Protocol Amendment filed in the UK to enable initiation of Phase 2 PARADIGME

Nordic Nanovector ASA (OSE: NANO) notes that information relating to an application for a Protocol Amendment to the LYMRIT 37-01 study, for the...


Nov 07, 2017, 08:26 ET Nordic Nanovector ASA (OSE: NANO) to Host Capital Markets Day and Present Q3 Results on 22 November 2017 in Oslo

Nordic Nanovector ASA (OSE: NANO) announces that its will host a Capital Markets Day and present its third quarter 2017 results on Wednesday 22...